Freedom Wealth Alliance’s Enliven Therapeutics ELVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-775
Closed -$12.7K 175
2022
Q4
$12.7K Buy
+775
New +$12.7K 0.02% 256